AiVF
Manager
Fund |
Fund manager
Co-invested company
sector
Healthcare
regional split
Rest of the world
vintage
status
Portfolio
category
A must
Insight Partners XII
Insight Partners

AiVF

Co-invested company
AiVF is revolutionizing in vitro fertilization (IVF) by using artificial intelligence to improve the outcomes and efficiency of fertility clinics. Its EMA platform evaluates embryos 50 times faster and with increased accuracy compared to a human embryologist, helping to help couples start a family.
Photo of a child representing AiVF, from the portfolio Fund manager private equity Fund manager  Insight Partners

AiVF key figures

2018
year of inception
1 bn
expected births via IVF by 2099
98%
faster to detect problems in embryos than traditional methods
60
employees
Data as at
5/5/26
*Source: Public data from companies’ websites and social media accounts. For more up-to-date information, we invite our investors to view the report made available on their space.

The fpci The Altaroc Odyssey private equity fund is no longer accepting new investments.

About AiVF

Thanks to the use of artificial intelligence, Israeli company AiVF has developed the latest generation of in vitro fertilization (IVF) techniques, meeting a growing need in the fertility field.

Since the first IVF baby was born in 1978, this technology has brought millions of children into the world. However, current methods are often costly and cannot keep pace with growing demand. Projections indicate that by the end of the 21st century, one billion children could be born thanks to IVF.

Founded by embryologist Daniella Gilboa and fertility professor Daniel Seidman, AiVF was created in response to these challenges. Initially conceived as a thesis topic, the idea was to combine clinical embryology and data science. Thus was born EMA, the world's first platform based entirely on artificial intelligence, using machine learning and computer-aided vision algorithms.

This platform reduces the time to conception, increases predictability and improves success rates. By automating data and establishing standardized procedures, clinics can speed up the IVF process, while ensuring patient well-being.

The results are impressive: in clinics using this technology in Europe and the USA, the EMA platform is 50 times faster and 48% more accurate than a human embryologist.

As Daniella Gilboa explains, "our vision is to help people realize their dream of starting a family. We provide innovative solutions in the field of fertility, while contributing to the future of reproductive medicine".

In the same sector as AiVF

Company videos
No items found.

Discover the new Vintage Altaroc Odyssey

Discover the Vintage Altaroc Horizon

Insight Partners
Odyssey 2021
Odyssey 2021
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Welcome to Altaroc
To provide you with a tailored experience, please complete your profile.
Please fill out your profile to access the site
country of tax residence
Select
choosenCountry
Preferred language
Select
choosenLang
YOUR INVESTOR PROFILE
Financial intermediary or professional investor
Financial advisors, wealth managers, private bankers, or any other investment service providers.
Qualified Investor or Altaroc Investor
Experienced investor or Altaroc investor
Private investors who have already invested with Altaroc or who have a minimum investment capacity of €100,000.
Private investors who have previously invested in Altaroc who have a minimum investment capacity of 200,000 euros.
Non-professional (retail) investor
Individual investors with an investment capacity below €100,000.
Retail investors with an investment capacity of less than 200,000 euros.
Institutional investor
Pension funds, retirement schemes, asset management companies, and single-family offices.
Select your language and investor profile to continue
Select your investor profile to continue
Scroll down to accept General Terms and Conditions
The webpage you are trying to access is not available in your country.